pubmed-article:14501494 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C0009924 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C1563732 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C1521827 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
pubmed-article:14501494 | lifeskim:mentions | umls-concept:C1100475 | lld:lifeskim |
pubmed-article:14501494 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:14501494 | pubmed:dateCreated | 2003-9-22 | lld:pubmed |
pubmed-article:14501494 | pubmed:abstractText | Dendrimer-based magnetic resonance imaging (MRI) contrast agents offer many advantages including high levels of amplification. The objective of this research was to test the adequacy and viability of a new family of dendrimers for use as MRI contrast agents in vitro and in vivo. | lld:pubmed |
pubmed-article:14501494 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:language | eng | lld:pubmed |
pubmed-article:14501494 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14501494 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14501494 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14501494 | pubmed:month | Oct | lld:pubmed |
pubmed-article:14501494 | pubmed:issn | 0020-9996 | lld:pubmed |
pubmed-article:14501494 | pubmed:author | pubmed-author:BrechbielMart... | lld:pubmed |
pubmed-article:14501494 | pubmed:author | pubmed-author:WienerErik... | lld:pubmed |
pubmed-article:14501494 | pubmed:author | pubmed-author:WangSteven... | lld:pubmed |
pubmed-article:14501494 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14501494 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:14501494 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14501494 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14501494 | pubmed:pagination | 662-8 | lld:pubmed |
pubmed-article:14501494 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:meshHeading | pubmed-meshheading:14501494... | lld:pubmed |
pubmed-article:14501494 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14501494 | pubmed:articleTitle | Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. | lld:pubmed |
pubmed-article:14501494 | pubmed:affiliation | Department of Nuclear, Plasma and Radiological Engineering, University of Illinois at Urbana-Champaign, USA. | lld:pubmed |
pubmed-article:14501494 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14501494 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14501494 | lld:pubmed |